Jab1 promotes immune evasion and progression in acute myeloid leukemia models under oxidative stress
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci183761 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Nan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: COP9 Signalosome Complex, Leukemia, Myeloid, Acute, Oxidative Stress, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, Key Research and Development Program of Hubei Province.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) is the most common hematological malignancy. Leukemia stem cells exhibit high levels of oxidative stress, with ROS being the primary products of this stress, inducing the expression of c-JUN activation domain-binding protein 1 (Jab1). Previous studies have demonstrated that Jab1, as a transcriptional coactivator of c-JUN, promotes the malignant progression of AML under oxidative stress. However, its role in immune evasion is still under investigation. Here, we observed that knocking out Jab1 reduced the expression of immune checkpoints in vivo, effectively overcoming the immune evasion of AML. Interestingly, the deletion of Jab1 had no impact on the maturation of normal hematopoietic cells in mice. Mechanistically, Jab1 directly activated IGF2BP3 by driving the transcription factor c-JUN, consequently modulated the m 6 A modification of LILRB4 mRNA, and promoted immune evasion in AML. Finally, CSN5i-3 effectively disrupted the signaling pathway mediated by Jab1, thereby restoring cellular immune surveillance and halting the progression of AML. Thus, our results highlight the functional role of Jab1 in supporting AML survival and support the development of targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- College of Chemistry and Molecular Sciences and.
- Research Center for Lifespan Health, Wuhan University, Wuhan, China.
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
- Key Research and Development Program of Hubei Province
Zitieren
APA
Zhang, N., Wang, Q., Chen, G., Liu, L., Wang, Z., Ma, L., Liang, Y., Wu, J., Li, X., Liu, X., & Zhou, F. (2025). Jab1 promotes immune evasion and progression in acute myeloid leukemia models under oxidative stress. Journal of Clinical Investigation. https://doi.org/10.1172/jci183761
Vancouver
Zhang N, Wang Q, Chen G, Liu L, Wang Z, Ma L, et al. Jab1 promotes immune evasion and progression in acute myeloid leukemia models under oxidative stress. Journal of Clinical Investigation. 2025. doi:10.1172/jci183761
BibTeX
@article{Zhang2025,
author = {Zhang, Nan and Wang, Qian and Chen, Guopeng and Liu, Li and Wang, Zhiying and Ma, Linlu and Liang, Yuxing and Wu, Jinxian and Li, Xinqi and Liu, Xiaoyan and Zhou, Fuling},
title = {Jab1 promotes immune evasion and progression in acute myeloid leukemia models under oxidative stress},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci183761}
}
EUVIMED